Extract disease (3). An increased incidence of lung (16) and liver disease (4,
5) may occur in persons with intermediate levels of a,-antitrypsin.
Hepatocytes from patients with severe a,-antitrypsin deficiency contain abundant a,-antitrypsin protein (23) , and it has been postulated that the low serum level in these subjects is associated with a failure of release of the protein from hepatic ribosomes. Although the liver is thought to be the only site of synthesis of this protein (23) , no studies in vitro of a,-antitrypsin synthesis have been reported.
The present investigation was undertaken to examine the synthesis of a,-antitrypsin and its release from the liver in patients with Z Z and S Z deficiency, the M Z phenotype, and in normal subjects (Pi type MM).
MATERIALS AND METHODS a,-ANTITRYPSIN QUANTITATION A N D TYPING
The concentration of a,-antitrypsin in serum was determined Speculation both by an automated nephelometric method (22) and by electroimmunoassay (17) using monospecific antiserum to a,-antitrypStudies in vitro of the synthesis and release of a,-antitrypsin, as sin obtained from Atlantic Antibodies (28) . Genetic typing was shown in the present investigation, may reveal the molecular basis of performed by immunofixation with this antiserum after agarose this genetic disorder.
gel electrophoresis at pH 8.6 (15) . as well as crossed immunoelectrophoresis after starch gel electrophoresis at pH 4.95 (12) .
a,-Antitrypsin is a 50,000-dalton glycoprotein that accounts for about 90% of the total trypsin inhibitory capacity of normal human serum. It is also a major extracellular inhibitor of other proteolytic enrymes such as plasmin, elastase, collagenase, chymotrypsin, thrombin, and leukocyte proteases (18) .
Extensive genetic polymorphism for human a,-antitrypsin has been demonstrated ( I I) and over 20 alleles are known for the protease inhibitor (Pi) locus which controls a,-antitrypsin synthesis. The different alleles are expressed in 0,-antitrypsin bands, which, in general, differ in electrophoretic position from each other and from the common Pi M protein. Some of the Pi types are associated with lower serum concentrations than Pi M. Pi Z occurs at a concentration about 10% and Pi S at about 60% of Pi M.
Individuals homozygous for P i V h u s have 5 15% of the normal a,-antitrypsin level and heterozygotes for P i h n d PiS have about 30% of the normal concentration (10) . An allele with no detectablc product (Pi-) has also been described (25) and the heterozygotes for this gene have serum levels that arc accordingly reduced.
Individuals homozygous for Piz or Pi-or heterozygous P i T iare particularly prone to develop pulmonary emphysema as young adults (8) and liver disease as children (24) . Recently. panlobular emphysema alone (26) or with cirrhosis (13) (28) in either parent cven with special stains. Liver cells contained abundant lipofuscin granules. Immunofluorescence studies revealed isolated clusters of small greenish yellow fluorescent globules in the liver cells after staining with lluoresceinated antiscra to human 0,-antitrypsin. These could be differentiated from yellow-orange autofluorescence of lipofuscin. Rough endoplasmic reticulum cisternae filled with abundant fibrillar material were seen in several liver cells on electron microscopic examina-.ion. However, the number of cells containing this material was far less than in the biopsies of the ZZ patients.
In Vitro Synthesis of a,-Antitrypsin. Liver fragments from individuals with Pi type M and from subjects with Pi types Z Z and M Z incorporated 14C-labeled amino acids into a,-antitrypsin in vitro (Fig. 4) . In each case, the labeled protein was secreted into the tissue culture medium. N o newly synthesized protein was detectable intracellularly. The Pi t)pe of the a,-antitrypsin synthesized and secreted by each culture corresponded to the type found in the subject's serum.
The incorporation of 14C-labeled amino acids was shown to be Accumulation of a,-antitrypsin because of a secretory defect present (23) in a,-antitrypsin deficiency, may have led to feedback inhibition of synthesis. Hence, accumulation of the abnormal protein in liver cells may be a very slow process. Immunofluorescent methods fail to distinguish newly synthesized from preformed protein.
(2) A primary structural gene defect might result in both a decreased rate of synthesis and abnormal accumulation of gene product. In this regard a,-antitrypsin, type Z , has been shown to be deficient in sialic acid, both in the serum (2, 7) and in the liver (9, 20) . (3) Since no newly synthesized intracellular a,-antitrypsin was detected even in normal liver, it is probable that the newly synthesized normal protein is rapidly secreted, as has been demonstrated for the synthesis and secretion of albumin (21) and complement (6) . (4) A less likely possibility is that the Z protein may be heterogeneous, some accumulating and some being Previous studies in vivo have demonstrated a,-antitrypsin in hepatocytes by immunofluorescence (23) . Such studies d o not by themselves prove that synthesis occurs in the liver. However, the finding that the serum level of a,-antitrypsin rose to normal after liver transplantation in a ZZ-deficient subject (23) suggests strongly that the liver is the primary site of synthesis for this protein. Furthermore, the present studies provide new direct evidence for the hepatic synthesis of a,-antitrypsin.
The presence of PAS-positive, diastase-resistant, intracytoplasmic globulrs in the periportal hepatocytes of patients with liver disease due to a,-antitrypsin deficiency is now well established (23) . Electron microscopic studies have revealed dilated cisternae in the rough endoplasmic reticulum containing abundant fibrillar material. Liver from patients without 0,antitrypsin deficiency with or without cirrhosis generally d o not contain such globules. Recently it has been shown that individuals with a,-antitrypsin deficiency and pulmonary disease without evidence crf liver disease (14) , as well as heterozygous deficient individuals without clinical the result of net synthesis of a,-antitrypsin inasmuch as cyclohexi~n i d e (2 pg/ml) blocked the incorporation of labeled precursors, and there was no evidence f0.r nonspecific absorption of labeled amino acids to preformed protein.
Evidence is presented that short term cultuies of liver tissue synthesize and release 0,-antitrypsin. In each instance, the newly synthesized protein corresponded in Pi type to the serum a,-antitrypsin of the donor. Although the techniques used did not permit accurate quantitation, they did allow a semiquantitative estimate The Z Z and S Z patients in the present study had increased accumulation of a,-antitrypsin in the hepatocytes by light, electron, and/or fluorescence microscopy. However, in the M Z subjects, the globules were not seen in the liver by light microscopy; they were demonstrable by immunofluorescence technique. Electron microscopic examination confirmed the presence of rough endoplasmic cisternae filled with fibrillar material, but both this examination and the immunofluorescence studies showed considerably less intracellular al-antitrypsin than in the ZZ-deficient liver.
Diastase-resistant, PAS-positive bodies are not specific for al-antitrypsin deficiency, but may be seen in a variety of other liver diseases. We have identified such material in the liver of patients with cystic fibrosis, biliary atresia and neonatal hepatitis with giant cell transformation (without deficiency of a,-antitrypsin in the serum). In such patients, however, the globules do not show staining with fluoresceinated antibody to a,-antitrypsin, and they d o not appear to be lipofuscin or bilirubin pigment. Considerable further work is needed to characterize the globules found in these heoatic disorders. and to confirm the biochemical defect which prbduces the trapping of a,-antitrypsin in liver cells of patients with al-antitrypsin deficiency.
S U M M A R Y
These studies demonstrate synthesis and release of a,-antitrypsin i n vitro in short term liver cell cultures. Synthesis and secretion of both Z and M proteins have been detected; however, no intracellular trapping of newly synthesized protein was found.
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Cardiovascular Effects of Electrical Stimulation of the Forebrain in the Fetal Lamb

Extract
Modified stereotaxic techniques were applied to fetal lambs during the latter third of gestation. Electrical stimulation in the region of the hypothalamus in 10 acute experiments was associated with three patterns of arterial blood pressure and heart rate changes: a pressor-tachycardia response; a pure tachycardia response (abolished by propranolol); and a pure bradycardia response (abolished by atropine). The pressor-tachycardia response was examined in detail in 13 chronic preparations (115-135 days of gestation at operation). The systolic arterial blood pressure increase was never greater than 35 mm Hg and was probably blunted by the large noninnervated placental circulation. This pressure increase was abolished by phentolamine and was thus mediated by stimulation of a-adrenergic receptors. The initial tachycardia was prevented by propranolol and was due to P-adrenergic stimulation. The taaycardia was followed in a few seconds by a bradycardia, abolished by atropine and possibly a vagal baroreflex. The pressortachvcardia resaonse was accentuated in two lambs who were delivered spontaneously and were studied after birth. These studies indicate that a suprabulbar neural framework exists in the fetal lamb for influencing the cardiovascular system from as early as 90 days of gestation.
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Speculation
Since electrical stimulation in the region of the hypothalamus is associated with various changes in blood pressure and heart rate, it is possible that the upper brain stem in the late gestation fetus has a role in the central nervous regulation of the circulation. Complex cardiovascular patterns may be organized in this region in response to fetal stress.
Although most experiments on central nervous regulation of the circulation have been performed in mature animals, there is evidence that the fetal and neonatal cardiovascular systems are also under central autonomic control. Resting sympathetic and parasympathetic influences on the heart and blood vessels of the fetal lamb are present by 0.55 gestation (20) . Baroreflex (4, 17) and chemoreflex (7) responses can be elicited after 0.60 gestation and the nervous pathways almost certainly involve the lower brainstem. Gootrnan et a/. (I I) observed blood pressure and heart rate changes with electrical stimulation of the brainstem in anesthetized newborn piglets.
The developmental pattern of central nervous influences on the fetal circulation has not been studied although the above examples
